乘典

Chengdian Biology is a Shanghai-based biotechnology company focused on the discovery and development of innovative small molecule drugs and biologics. The company leverages advanced structure-based drug design (SBDD) and computational chemistry platforms to target challenging pathways in immunology and oncology. Chengdian aims to address significant unmet medical needs by developing high-potency, selective therapies for autoimmune diseases and inflammatory conditions. Currently, the company is advancing several programs through the pre-clinical stage, supported by a team of experts in medicinal chemistry and structural biology.